Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
A therapeutic dendritic cell-based vaccine for HIV-1 infection.
Thymidine analogue excision and discrimination modulated by mutational complexes including single amino acid deletions of Asp-67 or Thr-69 in HIV-1 reverse transcriptase.
Optimal antiviral switching to minimize resistance risk in HIV therapy.
Mechanisms involved in the selection of HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with nucleoside analogue therapy failure.
The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates.
Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains.
HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse?
Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure.
Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.